Literature DB >> 12748093

Thalamic involvement in sporadic Creutzfeldt-Jakob disease: a diffusion-weighted MR imaging study.

Henriette J Tschampa1, Petra Mürtz, Sebastian Flacke, Sebastian Paus, Hans H Schild, Horst Urbach.   

Abstract

BACKGROUND AND
PURPOSE: Recent neuropathologic research suggests thalamic involvement in sporadic Creutzfeldt-Jakob disease (sCJD), which has been disregarded in imaging studies. Diffusion-weighted (DW) MR imaging has the highest sensitivity for the detection of signal intensity (SI) abnormalities in CJD. We hypothesized that pathologic changes in the thalamus in sCJD can be detected by using a subtle analysis of DW MR imaging.
METHODS: Six sCJD patients and nine healthy controls were examined with a 1.5-T system by using DW single-shot spin-echo echo planar (b = 0, 1000 s/mm(2)), T2-weighted turbo spin-echo, and fluid-attenuated inversion recovery sequences. One patient was examined serially (3, 4, and 8 months after onset of symptoms). MR images were reviewed for SI changes in the striatum, hippocampus, mediodorsal thalamic nucleus (MD), and pulvinar thalami. Apparent diffusion coefficients (ADCs) were measured in these areas.
RESULTS: All sCJD patients showed increased SI on DW images in the striatum bilaterally. ADCs in these areas were significantly reduced. Four of six sCJD patients showed increased SI on DW images in the pulvinar thalami, whereas ADCs were significantly reduced in all patients (mean ADC +/- SEM: in patients with SI changes, 701 +/- 38; in patients without SI changes, 684 +/- 37; in controls, 853 +/- 15 [P <.0001]). No patient showed SI changes in the MD on DW images, whereas ADCs were significantly reduced in all (664 +/- 28 as compared with 800 +/- 24 in controls [P =.0011]). Serial measurements in one sCJD patient showed ADC reduction in the pulvinar thalami preceding the SI changes on DW images.
CONCLUSION: A quantitative analysis of DW images with ADC measurements shows slight MR imaging changes in the thalamus in sCJD when abnormal SI may not be present.

Entities:  

Mesh:

Year:  2003        PMID: 12748093      PMCID: PMC7975779     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  32 in total

1.  FLAIR MRI in sporadic Creutzfeldt-Jakob disease.

Authors:  M Zeidler; D A Collie; M A Macleod; R J Sellar; R Knight
Journal:  Neurology       Date:  2001-01-23       Impact factor: 9.910

2.  [Diffusion-weighted MRI in patients with Creutzfeldt-Jakob disease].

Authors:  S Kropp; M Finkenstaedt; I Zerr; A Schröter; S Poser
Journal:  Nervenarzt       Date:  2000-02       Impact factor: 1.214

3.  Diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors:  H A Kretzschmar; J W Ironside; S J DeArmond; J Tateishi
Journal:  Arch Neurol       Date:  1996-09

4.  Diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease.

Authors:  P Demaerel; A L Baert; L Vanopdenbosch; W Robberecht; R Dom
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

5.  Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus.

Authors:  M Jeffrey; W G Halliday; J Bell; A R Johnston; N K MacLeod; C Ingham; A R Sayers; D A Brown; J R Fraser
Journal:  Neuropathol Appl Neurobiol       Date:  2000-02       Impact factor: 8.090

6.  MRI evidence of cerebellar and hippocampal involvement in Creutzfeldt-Jakob disease.

Authors:  M A Poon; S Stuckey; E Storey
Journal:  Neuroradiology       Date:  2001-09       Impact factor: 2.804

7.  Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.

Authors:  P Parchi; A Giese; S Capellari; P Brown; W Schulz-Schaeffer; O Windl; I Zerr; H Budka; N Kopp; P Piccardo; S Poser; A Rojiani; N Streichemberger; J Julien; C Vital; B Ghetti; P Gambetti; H Kretzschmar
Journal:  Ann Neurol       Date:  1999-08       Impact factor: 10.422

8.  Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Bodemer; O Gefeller; M Otto; S Poser; J Wiltfang; O Windl; H A Kretzschmar; T Weber
Journal:  Ann Neurol       Date:  1998-01       Impact factor: 10.422

9.  Conspicuity and evolution of lesions in Creutzfeldt-Jakob disease at diffusion-weighted imaging.

Authors:  Takaki Murata; Yusei Shiga; Shuichi Higano; Shoki Takahashi; Shunji Mugikura
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

10.  Conflicting MRI signals from gliosis and neuronal vacuolation in prion diseases.

Authors:  Y L Chung; A Williams; D Ritchie; S C Williams; K K Changani; J Hope; J D Bell
Journal:  Neuroreport       Date:  1999-11-26       Impact factor: 1.837

View more
  23 in total

1.  Brain-water diffusion coefficients reflect the severity of inherited prion disease.

Authors:  H Hyare; S Wroe; D Siddique; T Webb; N C Fox; J Stevens; J Collinge; T Yousry; J S Thornton
Journal:  Neurology       Date:  2010-02-23       Impact factor: 9.910

2.  Creutzfeldt-jakob disease involvement of rolandic cortex: a quantitative apparent diffusion coefficient evaluation.

Authors:  Y-R Lin; G S Young; N-K Chen; W P Dillon; S Wong
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

3.  Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease.

Authors:  H J Tschampa; K Kallenberg; H A Kretzschmar; B Meissner; M Knauth; H Urbach; I Zerr
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

4.  Differences of apparent diffusion coefficient values in patients with Creutzfeldt-Jakob disease according to the codon 129 genotype.

Authors:  D Galanaud; D Dormont; S Haïk; J Chiras; J P Brandel; J P Ranjeva
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-27       Impact factor: 3.825

Review 5.  Other dementias.

Authors:  Gaida Krumina
Journal:  Neuroradiology       Date:  2011-09       Impact factor: 2.804

6.  Diffusion-weighted MRI findings and clinical correlations in sporadic Creutzfeldt-Jakob disease.

Authors:  Ting Gao; Jin-Hao Lyu; Jia-Tang Zhang; Xin Lou; Wei Zhao; Xiao-Wei Xing; Ming Yang; Yan Yao; Qing-Che Tan; Cheng-Lin Tian; Xu-Sheng Huang; Lin Ma; Sheng-Yuan Yu
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

7.  Familial Creutzfeldt-Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD.

Authors:  Oren S Cohen; Joab Chapman; Amos D Korczyn; Zeev Nitsan; Shmuel Appel; Chen Hoffmann; Hanna Rosenmann; Esther Kahana; Hedok Lee
Journal:  J Neurol       Date:  2014-12-19       Impact factor: 4.849

8.  High-b-value diffusion MR imaging and basal nuclei apparent diffusion coefficient measurements in variant and sporadic Creutzfeldt-Jakob disease.

Authors:  H Hyare; J Thornton; J Stevens; S Mead; P Rudge; J Collinge; T A Yousry; H R Jäger
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-10       Impact factor: 3.825

9.  Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers.

Authors:  Hedok Lee; Hanna Rosenmann; Joab Chapman; Peter B Kingsley; Chen Hoffmann; Oren S Cohen; Esther Kahana; Amos D Korczyn; Isak Prohovnik
Journal:  Brain       Date:  2009-03-24       Impact factor: 13.501

10.  Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study.

Authors:  Raffaele Lodi; Piero Parchi; Caterina Tonon; David Manners; Sabina Capellari; Rosaria Strammiello; Rita Rinaldi; Claudia Testa; Emil Malucelli; Barbara Mostacci; Giovanni Rizzo; Giulia Pierangeli; Pietro Cortelli; Pasquale Montagna; Bruno Barbiroli
Journal:  Brain       Date:  2009-09-15       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.